253 related articles for article (PubMed ID: 17372238)
1. Differences in risk factors for breast cancer molecular subtypes in a population-based study.
Yang XR; Sherman ME; Rimm DL; Lissowska J; Brinton LA; Peplonska B; Hewitt SM; Anderson WF; Szeszenia-Dabrowska N; Bardin-Mikolajczak A; Zatonski W; Cartun R; Mandich D; Rymkiewicz G; Ligaj M; Lukaszek S; Kordek R; García-Closas M
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):439-43. PubMed ID: 17372238
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of basal-like breast cancer.
Millikan RC; Newman B; Tse CK; Moorman PG; Conway K; Dressler LG; Smith LV; Labbok MH; Geradts J; Bensen JT; Jackson S; Nyante S; Livasy C; Carey L; Earp HS; Perou CM
Breast Cancer Res Treat; 2008 May; 109(1):123-39. PubMed ID: 17578664
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology of triple-negative breast cancer, including race.
Trivers KF; Lund MJ; Porter PL; Liff JM; Flagg EW; Coates RJ; Eley JW
Cancer Causes Control; 2009 Sep; 20(7):1071-82. PubMed ID: 19343511
[TBL] [Abstract][Full Text] [Related]
4. Association between common risk factors and molecular subtypes in breast cancer patients.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
[TBL] [Abstract][Full Text] [Related]
5. How many etiological subtypes of breast cancer: two, three, four, or more?
Anderson WF; Rosenberg PS; Prat A; Perou CM; Sherman ME
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25118203
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China.
Xing P; Li J; Jin F
Med Oncol; 2010 Sep; 27(3):926-31. PubMed ID: 19771534
[TBL] [Abstract][Full Text] [Related]
7. Triple-negative breast cancer: clinical features and patterns of recurrence.
Dent R; Trudeau M; Pritchard KI; Hanna WM; Kahn HK; Sawka CA; Lickley LA; Rawlinson E; Sun P; Narod SA
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4429-34. PubMed ID: 17671126
[TBL] [Abstract][Full Text] [Related]
8. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.
Badve S; Dabbs DJ; Schnitt SJ; Baehner FL; Decker T; Eusebi V; Fox SB; Ichihara S; Jacquemier J; Lakhani SR; Palacios J; Rakha EA; Richardson AL; Schmitt FC; Tan PH; Tse GM; Weigelt B; Ellis IO; Reis-Filho JS
Mod Pathol; 2011 Feb; 24(2):157-67. PubMed ID: 21076464
[TBL] [Abstract][Full Text] [Related]
9. Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk.
Phipps AI; Buist DS; Malone KE; Barlow WE; Porter PL; Kerlikowske K; Li CI
Breast Cancer Res Treat; 2011 Apr; 126(3):671-8. PubMed ID: 20814817
[TBL] [Abstract][Full Text] [Related]
10. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
Cheang MC; Chia SK; Voduc D; Gao D; Leung S; Snider J; Watson M; Davies S; Bernard PS; Parker JS; Perou CM; Ellis MJ; Nielsen TO
J Natl Cancer Inst; 2009 May; 101(10):736-50. PubMed ID: 19436038
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer Epidemiology, Prevention, and Screening.
Winters S; Martin C; Murphy D; Shokar NK
Prog Mol Biol Transl Sci; 2017; 151():1-32. PubMed ID: 29096890
[TBL] [Abstract][Full Text] [Related]
12. Established breast cancer risk factors and risk of intrinsic tumor subtypes.
Barnard ME; Boeke CE; Tamimi RM
Biochim Biophys Acta; 2015 Aug; 1856(1):73-85. PubMed ID: 26071880
[TBL] [Abstract][Full Text] [Related]
13. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.
Bauer KR; Brown M; Cress RD; Parise CA; Caggiano V
Cancer; 2007 May; 109(9):1721-8. PubMed ID: 17387718
[TBL] [Abstract][Full Text] [Related]
14. Protooncogenic Role of
Naeimzadeh Y; Ilbeigi S; Dastsooz H; Rafiee Monjezi M; Mansoori Y; Tabei SMB
Biomed Res Int; 2023; 2023():8236853. PubMed ID: 38046902
[TBL] [Abstract][Full Text] [Related]
15. Cumulative environmental quality is associated with breast cancer incidence differentially by summary stage and urbanicity.
Gearhart-Serna LM; Mills BA; Hsu H; Fayanju OM; Hoffman K; Devi GR
Sci Rep; 2023 Nov; 13(1):20301. PubMed ID: 37985794
[TBL] [Abstract][Full Text] [Related]
16. Abbreviated Score to Assess Adherence to the 2018 WCRF/AICR Cancer Prevention Recommendations and Risk of Cancer in the UK Biobank.
Malcomson FC; Parra-Soto S; Ho FK; Celis-Morales C; Sharp L; Mathers JC
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):33-42. PubMed ID: 37909916
[TBL] [Abstract][Full Text] [Related]
17. Trajectories of body mass index in adulthood and risk of subtypes of postmenopausal breast cancer.
Busund M; Ursin G; Lund E; Wilsgaard T; Rylander C
Breast Cancer Res; 2023 Oct; 25(1):130. PubMed ID: 37898792
[TBL] [Abstract][Full Text] [Related]
18. Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis.
Mao X; Omeogu C; Karanth S; Joshi A; Meernik C; Wilson L; Clark A; Deveaux A; He C; Johnson T; Barton K; Kaplan S; Akinyemiju T
BMC Cancer; 2023 Jul; 23(1):644. PubMed ID: 37430191
[TBL] [Abstract][Full Text] [Related]
19. Obesity and Fibrosis: Setting the Stage for Breast Cancer.
Kuziel G; Moore BN; Arendt LM
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296891
[TBL] [Abstract][Full Text] [Related]
20. Cross-attention multi-branch CNN using DCE-MRI to classify breast cancer molecular subtypes.
Sun L; Tian H; Ge H; Tian J; Lin Y; Liang C; Liu T; Zhao Y
Front Oncol; 2023; 13():1107850. PubMed ID: 36959806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
